期刊文献+

巨噬细胞移动抑制因子ELISA方法的建立和应用研究 被引量:3

Development and Application of ELISA Method for Detecting Macrophage Migration Inhibitory Factor
下载PDF
导出
摘要 目的建立检测巨噬细胞移动抑制因子含量的ELISA检测法。方法采用方阵滴定法,比较4种封闭液、不同稀释度的捕获抗体、检测抗体和辣根过氧化酶标记链菌素对检测结果的影响,确定ELISA法的最佳实验条件。结果包被用捕获抗体的最适浓度为4mg/L,检测抗体的最适浓度为200mg/L,Streptavidin-HRP的最适稀释度为1∶5000。该方法的检测灵敏度为0.156μg/L,变异系数为7.3%~9.6%,回收率为91.2%~113.6%,与VEGF、TNF-α、IL-6、ICAM-1、胆红素、血红蛋白及甘油三酯均无交叉反应。结论建立的ELISA检测法简便、特异且灵敏,适用于检测血清中的MIF水平。 Objective To develop a new double antibody sandwich ELISA kit for detecting macmphage migration inhibitory factor. Method 4 kinds of block buffer, the different concentration of anti-MIF and biotin-anti-MIF,the different dilution of streptavidin-HRP are used for titration of ELISA test. Result The optimal concentration of anti-MIF was 4 mg/L and biotin-anti-MIF was 200 mg/L. The optimal dilutions of streptavidin-HRP were 1:5000. The sensitivity of this ELISA method was 0.156 μg/L. The variation coefficient was about 7.3%~9.6%, and the recovery rate was 91.2%~113.6%. Furthermore, there was no cross-reaction with VEGF, TNF-α, IL-6, ICAM-1, bilirubin, hemoglobin and triglyceride. Conclusion The ELISA method is a highly sensitive, specific and useful method to detect MIF in serum.
出处 《热带医学杂志》 CAS 2006年第6期672-674,共3页 Journal of Tropical Medicine
基金 国家自然科学基金(No.30300421 30571850) 广东省科技计划项目(No.2004B30601009) 广东省自然基金(No.04102307) 广东省医学科研基金(No.A2005047)
关键词 酶联免疫吸附测定 巨噬细胞移动抑制因子 动脉粥样硬化 ELISA macrophage migration inhibitory factor atherosclerosis
  • 相关文献

参考文献6

  • 1PAN JH, LINDHOLT JS, SUKHOVA GK, et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion [J]. J Vasc Surg, 2003,37(3) :628-635.
  • 2HERDER C, KOLB H, KOEING W, et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes:results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4) [J]. Diabetes Care,2006,29(2) : 368-371.
  • 3LUSIS AJ. Atherosclerosis [J]. Nature, 2000,407(6801):233-241.
  • 4LIN SG, YU XY, CHEN YX, et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits [J]. Circ Res, 2000,87(12) : 1202-1208.
  • 5BOZZA M, SATOSKAR AR, LIN G, et al. Targeted disruption of macrophage migration inhibitory factor gene reveals its critical role in sepsis [J]. J Exp Med,1999,189(2) : 341-346.
  • 6BURGER-KENTISCHER A,GOEBEL H, SELLER R, et al.Expression of macrophage migration Ⅰ nhibitory factor in different stages of human atherosclerosis [J]. Circulation,2002, 105(13): 1561-1566.

同被引文献31

  • 1刘冬妍,刘沛.肠道分泌型IgA的成分及功能[J].世界华人消化杂志,2004,12(12):2845-2848. 被引量:30
  • 2张启芳,唐国都.巨噬细胞移动抑制因子与消化系炎症性疾病[J].中国现代医学杂志,2006,16(5):720-723. 被引量:7
  • 3张雪光,师锁柱,陈香美,尹忠,李建军.巨噬细胞移动抑制因子在IgA肾病中的表达及意义[J].中国组织化学与细胞化学杂志,2006,15(3):313-318. 被引量:18
  • 4魏茂提.巨噬细胞移动抑制因子在细胞信号传导中的作用[J].武警医学院学报,2007,16(1):76-80. 被引量:1
  • 5[3]Giugliano LG,Ribeiro ST,Vainstein MH,et al.Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli[J].J Med Microbiol,1995,42:3.
  • 6[4]Dallas SD,Rolfe RD.Binding of Clostridium difficile toxin A to human milk secretory component[J].J Med Microbiol,1998,47:879.
  • 7[5]De Araujo AN,Gugliano LG.Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to Hela cells[J].BMC Microbiol,2001,1:25.
  • 8[6]Hammerschmidt S,Talay SR,Brandtzaeg P,et al.,A novel pnemococcal surface protein with specific binding to secretory immnoglobulin A and secretory component[J].Mol Microbiol,1997,25:1113.
  • 9[7]Lamkhioued B,Gounni AS,Gruart V,et al.Human eosinophils express a receptor for secretory component.Role in secretory IgA-dependent activation[J].Eur J Immunol,1995,25:117.
  • 10[8]Motegi Y,Kita H,Kato M,et al.Role of secretory IgA,secretory component,and eosinophils in mucosal inflammation[J].Int Arch Allergy Immunol,2000,122(suppl1):25

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部